NEW YORK, Nov 16 (Reuters) - U.S. Treasury yields rose on Monday and the yield curve steepened as news of another promising coronavirus vaccine boosted optimism that the economy may be closer to returning to normal, but that was tempered by a likely slow rollout.
Moderna Inc's experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker in as many weeks to report results that far exceeded expectations.
Benchmark 10-year yields rose 1.5 basis points to 0.908%.
The yields reached an eight-month high of 0.975% last Monday, ahead of new supply of three-year, 10-year and 30-year debt as part of the Treasury's quarterly refunding.
The yield curve between two-year and 10-year notes steepened one basis point to 73 basis points.
The Federal Reserve Chairman, Jerome Powell will speak on Tuesday at a Bay Area Council Business Hall of Fame awards event.
Read more from the original article:
風險提示：本文所述僅代表作者個人觀點，不代表 Followme 的官方立場。Followme 不對內容的準確性、完整性或可靠性作出任何保證，對於基於該內容所採取的任何行為，不承擔任何責任，除非另有書面明確說明。
暫無評論，立馬搶沙發